OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ubiquitin ligases in oncogenic transformation and cancer therapy
Daniela Senft, Jianfei Qi, Ze’ev A. Ronai
Nature reviews. Cancer (2017) Vol. 18, Iss. 2, pp. 69-88
Open Access | Times Cited: 404

Showing 1-25 of 404 citing articles:

mRNAs, proteins and the emerging principles of gene expression control
Christopher Buccitelli, Matthias Selbach
Nature Reviews Genetics (2020) Vol. 21, Iss. 10, pp. 630-644
Closed Access | Times Cited: 928

Targeting transcription factors in cancer — from undruggable to reality
John H. Bushweller
Nature reviews. Cancer (2019) Vol. 19, Iss. 11, pp. 611-624
Open Access | Times Cited: 729

The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng, Tong Meng, Lei Chen, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 537

The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
Lei Ding, Jiaqi Cao, Wen-Shan Lin, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 1960-1960
Open Access | Times Cited: 460

p53 modifications: exquisite decorations of the powerful guardian
Yanqing Liu, Omid Tavana, Wei Gu
Journal of Molecular Cell Biology (2019) Vol. 11, Iss. 7, pp. 564-577
Open Access | Times Cited: 339

Ubiquitin–proteasome system (UPS) as a target for anticancer treatment
Jin‐Young Park, Jinhong Cho, Eun Joo Song
Archives of Pharmacal Research (2020) Vol. 43, Iss. 11, pp. 1144-1161
Open Access | Times Cited: 287

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Li Guo, Yuan Tian, Wei‐Guo Zhu
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 271

E3 ubiquitin ligases: styles, structures and functions
Quan Yang, Jinyao Zhao, Dan Chen, et al.
Molecular Biomedicine (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 221

Targeted Intracellular Delivery of Antibodies: The State of the Art
Tatiana A. Slastnikova, A. V. Ulasov, Andrey A. Rosenkranz, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 180

Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
Maria Laura De Angelis, Federica Francescangeli, Filippo La Torre, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 180

The RING finger protein family in health and disease
Chunmei Cai, Yan‐Dong Tang, Jingbo Zhai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 107

PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells
Amirhosein Maharati, Meysam Moghbeli
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 77

The lncRNA BDNF-AS/WDR5/FBXW7 axis mediates ferroptosis in gastric cancer peritoneal metastasis by regulating VDAC3 ubiquitination
Guoquan Huang, Zhenxian Xiang, Haitao Wu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 4, pp. 1415-1433
Open Access | Times Cited: 76

Strategies for designing proteolysis targeting chimaeras (PROTACs)
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 74

Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Bin Song, Ping Yang, Shuyu Zhang
Cancer Communications (2024) Vol. 44, Iss. 3, pp. 297-360
Open Access | Times Cited: 30

Immune-related diagnostic markers for benign prostatic hyperplasia and their potential as drug targets
Yaxuan Wang, Jing Wang, Ji‐Bin Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 19

Targeting the cell cycle in breast cancer: towards the next phase
Kelsie L. Thu, Isabel Soria‐Bretones, TW Mak, et al.
Cell Cycle (2018) Vol. 17, Iss. 15, pp. 1871-1885
Open Access | Times Cited: 147

Injectable Hydrogels for Localized Cancer Therapy
Daoyang Fan, Yun Tian, Zhongjun Liu
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 137

m6A modification in RNA: biogenesis, functions and roles in gliomas
Yuhao Zhang, Xiuchao Geng, Qiang Li, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 128

The Skp2 Pathway: A Critical Target for Cancer Therapy
Zhen Cai, Asad Moten, Danni Peng, et al.
Seminars in Cancer Biology (2020) Vol. 67, pp. 16-33
Open Access | Times Cited: 127

Downregulation of RNF128 activates Wnt/β-catenin signaling to induce cellular EMT and stemness via CD44 and CTTN ubiquitination in melanoma
Chuanyuan Wei, Meng-Xuan Zhu, Yanwen Yang, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 124

Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages
Mei Song, Oladapo O. Yeku, Sarwish Rafiq, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 124

Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs
Miriam Girardini, Chiara Maniaci, Scott J. Hughes, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 12, pp. 2466-2479
Open Access | Times Cited: 117

Page 1 - Next Page

Scroll to top